Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Human parvovirus B19 (B19V) infection is known to cause serious consequences in immuno-compromized individuals. The present cross sectional study was designed to estimate the prevalence and genotype distribution of B19V in children receiving chemotherapy for solid malignancies at a tertiary care hospital in North India during October 2013 to May 2015. Serum samples from all the patients were tested for anti-B19V IgM and IgG antibodies and for B19V-DNA as soon as received. Samples testing positive for B19V-DNA were subjected to viral load estimation and to genotype determination by sequencing. Total 96 children were enrolled of which 9 (9.3%), 32 (33.3%), and 25 (26%) tested positive for anti-B19V IgM, anti-B19V IgG, and B19V-DNA, respectively. The viral load of B19V-DNA positive children ranged from 5.5 × 10(2) to 3.5 × 10(12) copies/ml. Accordingly children were divided into three groups: group I, with acute infection (n = 25); group II, previously exposed (n = 27), and group III, negative for B19V infection or with inappropriate antibody response (n = 44). B19V positivity was significantly associated (P-value < 0.0001) with a history of blood transfusion in the past 6 months, severe anemia (hemoglobin levels <6 gm%) and thrombocytopenia (platelets <150,000/cu.mm.). Sequence analysis of 21 of 25 DNA positive samples showed that all of them were Genotype 3b that clustered into three groups. All the sequences within each cluster were identical. The nucleotide identity of the sequences suggests a nosocomial outbreak of B19V during the study period. Children on chemotherapy for solid tumors should be routinely screened for B19V infection by both serology and PCR. J. Med. Virol. 88:1922-1929, 2016. © 2016 Wiley Periodicals, Inc.
Department of Microbiology, King George's Medical University, Lucknow, India.
Amita
A
Jain
Department of Microbiology, King George's Medical University, Lucknow, India.
Parul
P
Jain
Department of Microbiology, King George's Medical University, Lucknow, India.
Shantanu
S
Prakash
Department of Pediatrics, King George's Medical University, Lucknow, India.
Archana
A
Kumar
Department of Microbiology, King George's Medical University, Lucknow, India.
Danish N
DN
Khan
Department of Microbiology, King George's Medical University, Lucknow, India.
Akansha
A
Seth
Department of Microbiology, King George's Medical University, Lucknow, India.
Shikha
S
Gupta
Vice Chancellor, King George's Medical University, Lucknow, India.
Ravi
R
Kant
D000293:Adolescent; D000740:Anemia; D000914:Antibodies, Viral / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001782:Blood Donors; D002648:Child; D002673:Child, Hospitalized; D002675:Child, Preschool; D003428:Cross Infection / Q000821:virology; D004279:DNA, Viral / Q000097:blood; D005260:Female; D005838:Genotype; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007194:India; D008297:Male; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D010322:Parvoviridae Infections / Q000150:complications / Q000175:diagnosis / Q000821:virology*; D016732:Parvovirus B19, Human / Q000235:genetics* / Q000302:isolation & purification; D017422:Sequence Analysis, DNA; D062606:Tertiary Care Centers; D013921:Thrombocytopenia; D019562:Viral Load
D000914:Antibodies, Viral; D000970:Antineoplastic Agents; D004279:DNA, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M
India; chemotherapy; genotype; human parvovirus B19; solid malignancy